156 related articles for article (PubMed ID: 9048284)
1. Use of probe drugs as predictors of drug metabolism in humans.
Kivistö KT; Kroemer HK
J Clin Pharmacol; 1997 Jan; 37(S1):40S-48S. PubMed ID: 9048284
[TBL] [Abstract][Full Text] [Related]
2. Update: genetic polymorphism of drug metabolizing enzymes in humans.
Tanaka E
J Clin Pharm Ther; 1999 Oct; 24(5):323-9. PubMed ID: 10583694
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of 5-fluorouracil on human cytochrome P(450) isoforms in human liver microsomes.
Park JY; Kim KA
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):407-9. PubMed ID: 12904931
[TBL] [Abstract][Full Text] [Related]
4. Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.
Streetman DS; Bertino JS; Nafziger AN
Pharmacogenetics; 2000 Apr; 10(3):187-216. PubMed ID: 10803676
[TBL] [Abstract][Full Text] [Related]
5. Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs.
Lieu C; Shi J; Donat F; Van Horn R; Brian W; Newton J; Delbressine L; Vos R
Clin Pharmacokinet; 2002; 41 Suppl 2():19-26. PubMed ID: 12383041
[TBL] [Abstract][Full Text] [Related]
6. Sex-specific differences in CYP450 isoforms in humans.
Scandlyn MJ; Stuart EC; Rosengren RJ
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):413-24. PubMed ID: 18524030
[TBL] [Abstract][Full Text] [Related]
7. Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes.
Gao N; Tian X; Fang Y; Zhou J; Zhang H; Wen Q; Jia L; Gao J; Sun B; Wei J; Zhang Y; Cui M; Qiao H
Eur J Pharm Sci; 2016 Sep; 92():86-97. PubMed ID: 27339126
[TBL] [Abstract][Full Text] [Related]
8. Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.
Gervasini G; Carrillo JA; Benitez J
Clin Pharmacokinet; 2004; 43(11):693-706. PubMed ID: 15301574
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
Frye RF; Branch RA
Br J Clin Pharmacol; 2002 Feb; 53(2):155-62. PubMed ID: 11851639
[TBL] [Abstract][Full Text] [Related]
10. Investigation of sarizotan's impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial.
Krösser S; Neugebauer R; Dolgos H; Fluck M; Rost KL; Kovar A
Eur J Clin Pharmacol; 2006 Apr; 62(4):277-84. PubMed ID: 16525816
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
Walzer M; Bekersky I; Blum RA; Tolbert D
Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
[TBL] [Abstract][Full Text] [Related]
13. Screening of drug metabolizing enzymes for fusidic acid and its interactions with isoform-selective substrates in vitro.
Chen D; Lin XX; Zhao Q; Xiao J; Peng SF; Xiao MF; Ouyang DS; Tan ZR; Wang YC; Peng JB; Zhang W; Chen Y
Xenobiotica; 2017 Sep; 47(9):778-784. PubMed ID: 27571049
[TBL] [Abstract][Full Text] [Related]
14. 2D SMARTCyp reactivity-based site of metabolism prediction for major drug-metabolizing cytochrome P450 enzymes.
Liu R; Liu J; Tawa G; Wallqvist A
J Chem Inf Model; 2012 Jun; 52(6):1698-712. PubMed ID: 22631565
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human cytochrome P450 isoenzymes involved in the metabolism of vinorelbine.
Beulz-Riché D; Grudé P; Puozzo C; Sautel F; Filaquier C; Riché C; Ratanasavanh D
Fundam Clin Pharmacol; 2005 Oct; 19(5):545-53. PubMed ID: 16176333
[TBL] [Abstract][Full Text] [Related]
16. Risk assessment of accidental nortriptyline poisoning: the importance of cytochrome P450 for nortriptyline elimination investigated using a population-based pharmacokinetic simulator.
Jornil J; Jensen KG; Larsen F; Linnet K
Eur J Pharm Sci; 2011 Oct; 44(3):265-72. PubMed ID: 21854846
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
Anderson GD
Clin Pharmacokinet; 2005; 44(10):989-1008. PubMed ID: 16176115
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine.
Fang J; Coutts RT; McKenna KF; Baker GB
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):592-9. PubMed ID: 9840430
[TBL] [Abstract][Full Text] [Related]
19. Gender-related differences in pharmacokinetics and their clinical significance.
Tanaka E
J Clin Pharm Ther; 1999 Oct; 24(5):339-46. PubMed ID: 10583696
[TBL] [Abstract][Full Text] [Related]
20. Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms.
Or PM; Lam FF; Kwan YW; Cho CH; Lau CP; Yu H; Lin G; Lau CB; Fung KP; Leung PC; Yeung JH
Phytomedicine; 2012 Apr; 19(6):535-44. PubMed ID: 22261394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]